Massachusetts, United States, August 2025 – Manoj Raghunandanan has been appointed as the Chief Growth Officer at Insulet Corporation, where he will lead the company’s newly created Growth organization. His responsibilities will include uniting franchise teams, insights, customer experience, and commercial capabilities to strengthen Insulet’s global presence and expand access to its life-changing diabetes technology. With more than two decades of consumer marketing leadership across global organizations, Manoj brings proven expertise in scaling brands and driving strategic growth.
Before joining Insulet, Manoj served at Kenvue as Area Managing Director for Northern Europe, where he led a 400+ person cross-functional team across the UK and Nordic countries, managing a ~$1B P&L. He grew the business by 4%, enhanced profit margins, and drove market share expansion across iconic brands including AVEENO, Calpol, Listerine, and Nicorette. Prior to that, he was Global Head of Self Care & Consumer Experience, overseeing a $6B portfolio, leading strategy, insights, marketing excellence, and data analytics.
Earlier, Manoj built a long career at Johnson & Johnson, where he spent nearly 16 years in progressive leadership roles. He was President of Global Self Care and Consumer Experience Organization, where he played a pivotal role in the separation of J&J Consumer Health to form Kenvue, a $16B consumer company. He also held key leadership roles such as Vice President of Marketing, US OTC, overseeing a $2B retail portfolio, Sr. Director Marketing for the U.S. pain franchise (Tylenol, BenGay, Motrin), Sr. Director Innovation in Singapore, and Group Brand Director.
He began his career in brand management at Pfizer Consumer Health before moving into multiple senior marketing and innovation roles at J&J, contributing significantly to growth, product pipeline development, and customer-centric strategies.
Manoj holds a Master of Business Administration (MBA) in Marketing from the Fox School of Business at Temple University. He also studied at Temple University, further strengthening his foundation in marketing and strategy.
About Insulet Corporation
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is a global leader in medical technology, best known for its Omnipod Insulin Management System. Omnipod provides a tubeless, wearable insulin delivery solution that allows for up to three days of continuous insulin without the need for multiple daily injections or fingersticks. Its flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with continuous glucose monitors and smartphones, delivering a seamless and simplified diabetes management experience.
Operating in 25 countries worldwide, Insulet continues to advance its mission of improving the lives of people with diabetes through innovation, accessibility, and customer-focused solutions.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
